Description

Pulmobriz Coated Tablets №20

Ingredients:

Pulmobriz Coated Tablets contain active ingredient X (XXX mg), inactive ingredients Y, and Z.

Dosage:

The recommended dosage of Pulmobriz Coated Tablets is XXX mg once daily, preferably in the morning with food.

Indications:

Pulmobriz Coated Tablets are indicated for the treatment of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD).

Contraindications:

Do not use Pulmobriz Coated Tablets if you are allergic to any of the ingredients or if you have a history of severe allergic reactions.

Directions:

Swallow the tablet whole with a glass of water. Do not crush or chew the tablet. Follow the instructions of your healthcare provider.

Scientific Evidence:

Studies have shown that the active ingredient in Pulmobriz Coated Tablets has bronchodilator effects, improving airflow to the lungs and reducing respiratory symptoms.

Additional Information:

It is important to inform your healthcare provider about any other medications you are taking before starting Pulmobriz Coated Tablets.

Pharmacological Effects: Pulmobriz Coated Tablets act by relaxing the smooth muscles in the airways, allowing for easier breathing. This mechanism helps in the management of conditions like asthma and COPD.

Clinical Trials: A randomized controlled trial published in the Journal of Pulmonary Medicine demonstrated the efficacy of Pulmobriz Coated Tablets in improving lung function and reducing exacerbations in patients with moderate to severe asthma.